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ABSTRACT 
Use of high-resolution metabolomics to assess changes in metabolic pathways  
associated with acute exposure to air pollutants.  
By 
ELIZABETH A. FINLON 
April 20, 2018 
INTRODUCTION:		Many	studies	have	examined	the	positive	effects	of	physical	activity	on	mortality	and	morbidity,	as	well	as	the	negative	impact	of	exposure	to	air	pollutants.	Few,	however,	have	investigated	the	complex	interaction	between	physical	activity	and	air	pollution	exposure.	One	promising	method	for	analyzing	this	interaction	is	using	metabolomics	to	identify	the	resulting	metabolites	produced	from	each	exposure.	This	study	will	provide	insight	into	the	modification	by	physical	activity	of	health	biomarkers	associated	with	acute	exposure	to	air	pollutants.	
	
AIM:		The	aim	of	this	study	is	to	identify	novel	biomarkers	of	pollutant	exposures	using	metabolomics	analyses.	Specifically,	this	study	will	examine	differences	in	exposures	to	air	pollutants	(black	carbon,	ozone,	particulate	matter,	particle	number	concentration)	and	corresponding	metabolic	changes	in	subjects	before	and	after	outdoor	physical	activity.	
	
METHODS:		Sixty-five	saliva	samples	for	metabolomics	analysis	were	collected	from	a	sample	of	57	individuals	in	Atlanta,	GA	from	June	through	July	2016.	The	ambient	outdoor	concentrations	of	PM2.5	(PM),	ozone	(O3),	black	carbon	(BC),	and	particle	number	concentration	(PNC)	were	measured	throughout	each	2-hr	sampling	event.	Each	participant’s	physical	activity	levels	were	monitored	as	well.	Each	pollutant	(above)	was	analyzed	per	individual	via	four	separate	metrics:		ambient	outdoor	concentration,	exposure,	cumulative	inhaled	dose,	and	maximum	one-minute	dose.	Samples	were	processed	via	ultra-high	resolution	liquid	chromatography-mass	spectrometry.	Various	mixed	regression	models	used	pollutant	metrics	to	predict	changes	in	metabolic	feature	intensity	from	pre-	to	post-exposure.	Metabolite	identification	and	pathway	analysis	for	each	significant	feature	was	calculated	using	Mummichog	version	1.0.3	with	a	level	of	significance	of	.05.		
	
RESULTS:		All	pollutant	metrics	were	significantly	associated	with	changes	in	metabolic	features.	PNC	max	showed	the	highest	number	of	significant	associations	with	172	significantly	associated	metabolic	features.	Additionally,	Mummichog	analysis	yielded	significant	pathway	predictions	for	all	feature	metrics,	with	a	total	of	48	significant	metabolic	pathway	predictions	
	
	ii	
DISCUSSION:		We	identified	48	metabolic	pathways	that	showed	significant	correlation	with	air	pollution	exposure.	However,	the	lack	of	consistency	in	pathway	predictions	suggests	that	acute	pollution	exposure	may	take	more	than	2	hours	to	have	a	measurable	effect	on	the	salivary	metabolome.	Our	research	suggests	that	while	high-resolution	metabolomics	shows	potential	for	reliably	identifying	biomarkers	of	pollutant-related	stress,	there	is	still	much	room	for	further	development	in	this	field.	
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I. INTRODUCTION 
 
1.1 Background: 
 Environmental exposures, including pollutants, pharmaceuticals, and pesticides, can have 
a significant impact on the development of disease in humans. Environmental components are 
understood to play an important role in the development of many chronic diseases such as 
“cancer, cardiovascular diseases, respiratory diseases, and type 2 diabetes, which are among the 
leading causes of morbidity and mortality in human populations” (Cui et al. 2016). However, 
less emphasis has been placed on accurately measuring the environmental component of human 
health than has been placed on measuring the impact of one’s genetic makeup. To correct this, 
researchers have begun to study the human exposome in order to account for the totality of 
human non-genetic exposures throughout a lifetime. The exposome is considered the 
environmental compliment to the human genome; understanding the exposome allows for a more 
in-depth evaluation of the association between environmental exposures and resulting biological 
effects than would examining the genome alone (Louis et al. 2017). Furthermore, recognizing the 
role of the complex interaction between one’s genes and specific environmental exposures 
allows for a deeper understanding of the impacts of environment on human health. 
 While physical activity and exposure to air pollutants each have independent (usually 
opposing) effects on human health (Fisher et al. 2016), it is important to understand the complex 
interplay between these two factors when one is exposed to both simultaneously (Greenwald et 
al. 2016). To fully comprehend this interaction, we must recognize which metabolic interactions 
occur due to physical activity, which result from exposure to air pollution, and how these 
metabolites interact with each other.  
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 Many studies have examined the positive effects of physical activity on mortality and 
morbidity, as well as the negative impact of exposure to air pollutants (Brook et al. 2010, 
Fogelholme 2010). Few, however, have investigated the complex interaction between physical 
activity and air pollution exposure. One promising method for analyzing this interaction is using 
metabolomics to identify the resulting metabolites produced from each exposure.  
1.2 Study Objectives: 
 It is well documented that exposure to air pollution is related to an increase in mortality 
and morbidity, particularly cardiovascular and respiratory diseases (Brook et al. 2010, Dominici 
et al. 2006, Kataonda et al. 2011). While exposure to air pollutants is known to increase the risk 
of premature mortality, the impact of such exposure on metabolite production is not well 
documented. Metabolites act as valuable biomarkers of disease development and can provide the 
ability to detect diseases at an early stage (Cox et al. 2014). The	exact	biochemical	mechanisms	linking	exposure	to	symptomatic	health	outcomes	are	not	precisely	known,	which	is	why	exploring	changes	to	intermediate	metabolites	is	an	important	scientific	endeavor.		
Metabolomics is quickly becoming an effective tool for monitoring disease occurrence in human 
populations.  
 The aim of this study is to identify novel biomarkers of pollutant exposures using 
metabolomics analyses. Specifically, this study will examine differences in exposures to air 
pollutants (black carbon, ozone, particulate matter, particle number concentration) and 
corresponding metabolic changes in subjects before and after outdoor physical activity. This 
study will provide insight into the modification by physical activity of health biomarkers 
associated with acute exposure to air pollutants.   
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II. REVIEW OF THE LITERATURE 
2.1 Air pollution and Physical Activity 
 Both short- and long-term exposure to air pollution are known to negatively impact 
mortality and morbidity, particularly through cardiovascular disease, respiratory disease, and 
neurological and reproductive disorders (Curtis et al. 2006). The effects of physical inactivity 
include obesity and type II diabetes and are consistently associated with increased morbidity and 
mortality (Fogelholm 2010, Flegal et al. 2013). Physical activity, which generally has a positive 
impact on health, increases one’s ventilation rate and, therefore, in the presence of pollution, 
increases the inhaled dose of air pollutants (de Hartog et al. 2010). Additionally, during exercise 
1) most air is inhaled through the mouth rather than the nose, thereby bypassing the nasal 
mechanisms of large particle filtration and 2) the increase in airflow velocity causes gaseous 
pollutants to pass deeper into the respiratory tract than they would if one were not breathing 
heavily (Ramos et al. 2015). More research is needed to determine whether the increase in 
minute ventilation during physical activity heightens the detrimental effects of short-term air 
pollution exposure to the point of outweighing the long-term benefits of physical activity on lung 
function (Fisher et al. 2016).  
 In this study, we focus on four pollutants:  particulate matter (PM2.5), ozone (O3), black 
carbon (BC), and particle number concentration (PNC). PM2.5 results primarily from vehicle 
emissions, diesel, coal combustion, and biomass burning (Pui et al. 2014). Because of its small 
size, PM2.5 deposits throughout the respiratory tract, leading to pulmonary and circulatory 
diseases (Pui et al. 2014). O3 is a secondary photochemical pollutant that is known to have 
adverse human health effects (Jenkin & Clemitshaw 2000). Exposure to elevated concentrations 
of O3 has been shown to result in inflammatory response as well as lung epithelial damage 
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(Gryparis et al. 2004). Traffic emissions are the primary source of BC pollution, which is 
produced by the incomplete combustion of carbonaceous fuel (Invernizzi et al. 2011). When 
inhaled, BC deposits deep into the respiratory tract where it has been shown to cause decreased 
lung function (Invernizzi et al. 2011). In urban settings, motor vehicle emissions represent the 
primary source of ultrafine particles, exposure to high concentrations of which has been 
associated with “elevated total, cardiovascular, and infant mortality” (Zhu et al. 2002, Kappos et 
al. 2004).  
2.2 Exposome: 
 The term “exposome,” coined by Christopher P. Wild in 2005, refers to the sum of all 
exposures of an individual throughout a lifetime (Vrijheid 2014). The term gives emphasis to the 
importance of the environment on human health outcomes and was originally created to align 
exposure research efforts with those of the human genome. The exposome functions as the 
environmental compliment to the human genome. While “genome” refers to the entirety of an 
individual’s internal DNA structure, “exposome” refers to one’s external exposures and the 
impact of those exposures on internal processes. Exposome research, therefore, focuses on an 
individual’s non-genetic exposures throughout the lifetime. Understanding the impact of human 
environmental exposures and behaviors allows for a more complete insight into one’s risk of 
disease. Since 2005, when research of the exposome began, the term has come to include 
exposure to both chemical components (pollutants, pharmaceuticals, radiation, etc.) as well as 
behavioral factors (stress, diet, physical activity, etc.) (Dennis et al. 2017).  
 Prior to studying the human exposome, “exposures” were viewed as arising strictly 
outside of the body. We now understand that bio-chemicals created endogenously such as 
metabolites and hormones can alter how our bodies interact with our specific environment, 
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causing a unique biological response (Cui et al. 2016). One important aspect of studying the 
human exposome is understanding the importance of each individual’s unique molecular disease 
process as a result of one’s specific internal and external exposures.  
 Studying the human exposome poses a distinct set of challenges. While the human 
genome is relatively stable over a lifetime, the human exposome “is a highly variable and 
dynamic entity that evolves throughout the lifetime of the individual” (Wild 2005). Additionally, 
studying the human exposome requires the ability to differentiate between the effects of many 
exposures over a lifetime. This complexity often requires exposome research to be divided into 
“focal areas” such as exposures during specific life stages (e.g. prenatal vs. early childhood) (Cui 
2016).  
 Despite the challenges, understanding the effect of one’s environment on gene expression 
and disease formation offers the opportunity to provide more effective risk assessment as well as 
disease prevention and treatment. Christopher P. Wild anticipates that gaining fundamental 
knowledge of “exposure-disease associations” at the human exposome level will serve to 
improve our comprehension of “disease etiology at the population level” (Wild 2005).  
2.3 Metabolomics: 
 Metabolites are byproducts of the series of reactions within cells that occur due to any 
chemical or non-chemical exposure. This series of individual chemical reactions is referred to as 
a “pathway.” Each pathway is comprised of a sequence of intermediate metabolites that, when 
grouped together, are unique to the specific pathway. Examples of metabolites include amino 
acids, fatty acids, and glucose molecules. (Harris n.d.) 
 Metabolomics analysis, a method of metabolic profiling, is the study of low molecular 
weight (approx. 50-1,500 daltons) metabolites that act as biomarkers for environmental 
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exposures (Cox et al. 2014.) Metabolites are essentially the byproducts of cellular-level 
processes, and understanding them reveals the impact of both endogenous and exogenous 
exposures on human health. Identifying and tracking alterations in metabolite levels is an integral 
step to improving our knowledge of the influence of environmental exposures on human health. 
Metabolome analysis can be incorporated into the study of public health via increasing our 
understanding of exposure (both chemical and non-chemical), gene-environment interactions, 
and disease risk factors (Athersuch 2016). 
 The study of metabolite biomarkers plays a particularly important role in determining the 
effects of environmental exposures. Understanding biomarkers of environmental exposures has 
the potential to alleviate some of the issues of misclassification in epidemiologic research, 
including inaccurate recall of exposure and inaccurate behavior modeling.  In his analysis of 
current metabolomics research, Athersuch states that “the human metabolome has the potential 
to report directly on a very large number of environmental exposures” and that these metabolites 
are detectable using common metabolic profiling methods. (Athersuch 2016)   
 Saliva is a quick and easy-to-collect medium for the identification of metabolites and 
metabolic pathways. It offers a non-invasive, inexpensive approach to metabolite analysis. 
Further development of the salivary metabolome will provide a basis for identifying disease-
related salivary biomarkers. Saliva is made of up approximately 99% water. The remaining 1% 
consists of “electrolytes, mucus, cellular debris, proteins, and small molecules” that are 
transferred from the blood via passive diffusion (Bessonneau et al. 2017). Thus, saliva displays 
various physiological conditions of the body on a molecular scale.  
 A common method of analyzing salivary metabolites is through liquid chromatography-
mass spectrometry (LC-MS). Liquid chromatography is used to separate and quantify ions or 
	7	
small molecules in a solvent. Two	commonly	used	chromatography	approaches	are 
hydrophilic-interaction liquid chromatography (HILIC) and reversed-phase liquid C18 
chromatography (C18). Each technique utilizes a specific column (either the HILIC or C18 
column) to separate chemicals in different ways. When	using	a	HILIC	column,	hydrophilic	compounds	are	preferentially	retained	by	the	stationary	phase	and	consequently	have	longer	retention	times,	whereas	when	using	a	C18	column,	hydrophilic	compounds	are	preferentially	in	the	mobile	phase	with	correspondingly	short	retention	times.	Hydrophobic	compounds	display	the	corresponding	inverse	relationship.	(Simon et al. 
2012)  
 In this study, the term “feature” is used to describe an unknown metabolite. A feature 
may be found in both C18 and HILIC datasets, but it will have different retention times on each 
column. Following liquid chromatography, mass spectrometry is used to ionize molecules in a 
sample and then sort the ions based on their mass-to-charge (m/z) ratio. Combining liquid 
chromatography’s ability to separate molecules with mass spectrometry’s capability to identify 
individual molecules based on mass allows for an in-depth analysis of various chemical 
compounds in any given saliva sample (Sugimoto et al. 2010).  
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III. METHODS 
3.1 Data Collection: 
 Data for this study was provided by the Study of Air Pollution and Physical Activity 
(SAPPA). The data was collected in Atlanta, GA from June through July 2016. The Georgia 
State University Institutional Review Board and the Emory University Institutional Review 
Board provided approval for this study. Adults provided written consent while individuals under 
the age of 18 provided both written and parental consent.   
 Samples for metabolomics analysis were collected from a sample of 57 individuals on an 
ultimate Frisbee team at Walker Park, on a soccer team at Piedmont Park, and at a football 
practice at Carver High School. The samples were collected over 9 sampling days. Repeated 
measures were performed on some of the participants on multiple days, resulting in 65 total 
samples from the 57 participants. The exposure period was an interval of approximately 2 hours, 
during which participants engaged in either athletic practice or competition. Prior to the 
beginning of physical activity, we recorded each participant’s self-reported date of birth, sex, and 
race and measured their height and weight. At the beginning and end of each day of 
participation, we collected a 1 mL saliva sample from study subjects and directed them in the 
performance of a pulmonary function test using a handheld spirometer (EasyOne Plus, ndd 
Medical Technologies Inc.). These tests included forced vital capacity (FVC), which is the 
volume of air that a person can forcibly exhale from their lungs with ordinary effort. In addition, 
participants were fitted with an electronic biomonitoring device (BioHarness 3, Zephyr 
Technology Corp.) worn as a strap around the torso. This device measures motion using 
accelerometry as well as heart and breathing rates. Accelerometry data is reported as an activity 
parameter (ACT), which is the magnitude of the vector sum of 3-dimensional acceleration, 
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expressed as a fraction of standard gravity (G-force). All BioHarness data is aggregated to one-
minute time resolution. Minute ventilation, or the volume of air a person inhales in one minute, 
is calculated according to an extensively-validated model developed by Greenwald and Hayat 
(personal communication) as a function of heart rate, breathing rate, age, height, sex, and FVC. 
The inhaled dose of an air pollutant is calculated as the product of minute ventilation and 
ambient concentration (described below).  
 We continuously measured the ambient concentration of several important gas- and 
particle-phase air pollutants. We measured PM2.5 (PM) using an Optical Particle Sizer (Model 
3330, TSI Inc.), ozone (O3) using a Model 202 Ozone Monitor (2B Tech), black carbon (BC) 
using a microaethalometer (Model AE51, Aethlabs Inc.), and particle number concentration 
(PNC) using a NanoScan particle sizer (Model 3306, TSI Inc.). Previous studies have shown that 
the majority of PM2.5 mass in the Atlanta area is secondary in nature and thus somewhat spatially 
homogenous (Bates et al. 2015). O3 is an entirely secondary pollutant and is spatially 
homogenous as well (Wade et al. 2006); however, BC and PNC are closely associated in the 
near-road environment with fresh emissions from diesel and gasoline sources, respectively (Zhu 
et al. 2002). 
 This study analyzed each pollutant (above) using four separate metrics:  ambient 
concentration, exposure, cumulative inhaled dose, and maximum one-minute dose. The ambient 
concentration exposure metric is defined as the average concentration of each pollutant during 
the exposure period as described above. The metric termed “exposure” is the average 
concentration of each pollutant multiplied by the length of the exposure period. Cumulative 
inhaled dose is the sum of all one-minute doses in an exposure period, and the maximum one-
minute dose metric is included in order to determine whether short-term (one-minute) exposures 
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have a significant impact on changes in metabolic profiles. The a priori expected order of 
biological relevance of these pollutant metrics was concentration, exposure, dose, with dose 
being the most relevant.  
3.2 Analysis: 
 Sixty-five sets of saliva samples were collected and processed via ultra-high resolution 
LC-MS, resulting in a dataset of individual metabolic “features” identified by their mass-to-
charge (m/z) ratios as well as retention times (rTime). These features indicate the change in an 
individual’s metabolic profile from pre- to post-exposure. These results were divided into two 
datasets based on the column utilized during liquid chromatography, C18 and HILIC.  The C18 
dataset consisted of 7,608 features, and the HILIC dataset consisted of 8,293 features. It is 
important to note that the same feature may appear in both datasets.  
 Each of the 65 samples was run through LC-MS three times. The chromatographic 
intensity values of the triplicate results were averaged to yield a single set of values per each m/z 
ratio. Next, we calculated the change in feature abundance as the post-exposure intensity minus 
the pre-exposure intensity. The resulting averages were then log-transformed in order to interpret 
the patterns in the data. Data was analyzed using RStudio version 3.3.3 packages lme4 and 
lmerTest to run various mixed regression models that used pollutant metrics to predict changes in 
feature intensity. Linear mixed models used each pollutant metric (exposure, dose, concentration, 
and maximum dose of BC, PNC, O3, and PM) as the predictor while controlling for the 
following covariates:  age, race, BMI, sex, and activity level during practice, allowing us to 
identify associations between changes in pollution metrics and changes in the presence of 
metabolic features from pre- to post-exposure. Because our dataset contained repeated measures 
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for some subjects, we included a random effect for subject in our models. The general linear 
mixed model was formulated as follows:  ∆𝐹𝑒𝑎𝑡𝑢𝑟𝑒!" = 𝜇 + 𝜃! + 𝛽!∆𝑃𝑜𝑙𝑙𝑢𝑡𝑎𝑛𝑡 𝑀𝑒𝑡𝑟𝑖𝑐!" + 𝛽!𝐴𝑔𝑒! + 𝛽!𝑆𝑒𝑥! + 𝛽!𝐵𝑀𝐼! + 𝛽!𝑅𝑎𝑐𝑒!+ 𝛽!𝐴𝑐𝑡!"  +  𝜀!" , 
where i indexes subject and j indexes sampling day.  
Models with pollutant metrics as the predictor were also run without controlling for activity in 
order to determine the features likely related to activity (metabolites produced by biochemical 
processes related to physical activity) rather than pollutant exposure.  Additionally, we ran a 
variation of the above model in order to assess the association between activity and metabolite 
production, without controlling for any pollution metrics:  ∆𝐹𝑒𝑎𝑡𝑢𝑟𝑒!" = 𝜇 + 𝜃! + 𝛽!𝐴𝐶𝑇!" + 𝛽!𝐴𝑔𝑒! + 𝛽!𝑆𝑒𝑥! + 𝛽!𝐵𝑀𝐼! + 𝛽!𝑅𝑎𝑐𝑒! +  𝜀!" , 
where indexing of variables and errors are as described for model 1.  
We ran these additional models because of the high correlation between the activity variable and 
factors used to measure ventilation rate, and by extension, dose.  
 The models were run through a metabolome-wide association framework, and p-values 
for the strength of association between each pollution metric and feature intensity were created. 
The p-values for each pollutant metric were adjusted for type I statistical errors using the 
Benjamini-Hotchberg false discovery rate (FDR) at FDR <0.05.  The FDR is used to control for 
the expected proportion of false discoveries in any statistical analysis.  At the <0.05 adjustment 
level, 5% of significant tests will result in false positives, rather than 5% of all tests resulting in 
false positives. This step is required because each model is repeated for every feature, resulting 
in thousands of p-values associated with each pollutant metric. The results of the FDR adjusted 
p-values were displayed via Manhattan plots of the –log10(p) over the feature retention time.  
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 Metabolite identification and pathway analysis for each significant feature was calculated 
using Mummichog version 1.0.3 with a cutoff significance value of <0.05.  Mummichog is a 
pathway analysis tool utilizing several libraries containing thousands of positively-identified 
metabolites with known m/z ratios. Mummichog predicts functional activity of metabolic 
features by computing “all possibly matched metabolites, and [it] searches the reference 
metabolic network for all the modules that can be formed by these tentative metabolites” (Li et 
al. 2013). The reference metabolic network used in Mummichog analysis is based on KEGG, 
UCSD Recon1 and Edinburgh human metabolic network (Li et al. 2013). The results we 
gathered from Mummichog convey the probability of the contribution of individual metabolic 
pathways to the response to acute air pollution exposure. Pathways from the experimental dataset 
were considered significant if they displayed at least 2 overlapping nodes with a given pathway 
and had a Mummichog calculated p-value of <0.05.  
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IV. RESULTS 
 Sixty-five saliva samples were collected from 57 participants over 9 separate sampling 
events. Characteristics of the sample population are described in Table 1. Pollutant metric values 
are indicated in Table 2.  
 After the FDR adjustment, all pollutant metrics for both C18 and HILIC datasets were 
significantly associated with changes in metabolic features. This is displayed in Table 3. PNC 
max showed the highest number of significant associations with 172 (73 from C18 and 99 from 
HILIC) significantly associated metabolic features. The Manhattan plots for PNC max are 
provided in Figure 1. In the plots, the direction of change from pre- to post-exposure for each 
feature is indicated by color; the effect size for each feature is indicated by color intensity. Each 
plot features 3 FDR-corrected significance levels: 0.05, 0.10, and 0.20 represented by the red, 
blue, and black lines, respectively. Figure 2 includes the Manhattan plots for BC dose.  BC dose 
provides an example of a more representative sample of the data collected in this study. Black 
carbon is a pollutant known to cause adverse health effects post-exposure. Additionally, dose is 
dependent upon both exposure and activity level, making it potentially the most biologically 
relevant exposure metric included in the study.  
 The Mummichog analysis yielded significant pathway predictions for all feature metrics. 
The results of this analysis are displayed in Table 4.  
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V. DISCUSSION 
5.1 Discussion of Results: 
 Of the 48 significant metabolic pathways via the Mummichog analysis, 20 are known to 
be associated with deleterious effects of air pollution exposure. Glutathione, for instance, was 
found to be significantly associated with PNC concentration and exposure as well as BC 
concentration. Glutathione is an antioxidant that responds to airway inflammation. Increases in 
glutathione-related oxidative stress have been associated with cause-specific mortality (Breton 
2010 & Weichenthal 2015). Leukotrienes are known bronchoconstrictors that play an important 
role in both “triggering acute asthma attacks and in causing longer term hypersensitivity of the 
airways in chronic asthma” cases (Berger 1999). Leukotrienes also play an important role in 
airway inflammation processes in people without asthma. Seeing an upregulation of these 
metabolites in healthy individuals could provide insight into the effects of pollutant exposure on 
lung health in non-asthmatics. In this analysis, leukotriene metabolism was found to be 
significantly associated with PNC max, concentration, and exposure; BC dose; and PM max.  In 
their 2008 study, Park et al. demonstrate that exposure to traffic-related ambient particles is 
associated with elevated plasma concentrations of homocysteine, an acid produced during 
methionine metabolism that “is a risk factor for atherosclerosis, myocardial infarction, stroke, 
and thrombosis” (Park et al. 2008). Additionally, aspartate, asparagine, tryptophan, and tyrosine 
are amino acids that have been linked to air pollution exposure in vivo and in vitro studies 
(Vlaanderen et al. 2017). The upregulation of glycerophospholipid metabolism, which we found 
to be highly correlated with PNC concentration, exposure, dose; Ozone exposure; and BC 
exposure, has previously been found to be associated with PM exposure from cigarette smoke in 
mice (Titz et al. 2016).  
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 Based on earlier research, 5 of the 48 significant metabolic pathways can be attributed to 
the participants’ physical activity levels rather than their exposure to air pollution. These 
pathways include purine metabolism, hexose phosphorylation, glycolysis and gluconeogenesis, 
and beta-alanine metabolism. (Zielinski & Kusy 2015, Bruunsgaard 2005, Hobson et al. 2012) 
 One of the expected results in this analysis was a consistent pattern of significant effects 
across the exposure metrics for a given pollutant. This is because exposure misclassification is 
reduced for more biologically relevant exposure metrics. For example, if two hypothetical 
subjects (A and B) experienced the same mean concentration of pollutants, but subject A was 
present for 90 minutes while subject B was present for 120 minutes, the time-corrected exposure 
metric would reflect this difference whereas the “concentration” exposure metric would not. 
Likewise, if subject A was relatively sedentary while subject B was very active with a higher 
ventilation rate, then the “dose” exposure metric would reflect this difference while the time-
corrected exposure would not. We hypothesized that as the biological relevance of a pollutant 
metric increases (e.g. from concentration to exposure to dose), the list of significantly associated 
metabolites would decrease (by eliminating spurious associations resulting from exposure 
misclassification) but not change entirely. In reality, the lists of associated metabolites had little 
to no overlap among metrics.  This surprising finding could potentially be explained in a few 
non-mutually-exclusive ways:  it could be a true finding arising from difficult to interpret 
differences between exposure metrics, it could be the result of confounding by some unexpected 
variable, or our results could be chance findings that resulted even after applying the FDR 
adjustment. This is plausible due to the very large number of models run for each metric. If this 
is the case, our results consist of chance findings, and the features identified as significant are not 
actually a part of any causal pathway of interest to us, and instead, the null hypothesis that there 
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are no detectable changes in metabolomic profile would be accepted. If the null hypothesis is 
correct, this could indicate that the exposure period utilized in this study was simply too short to 
accurately measure changes in metabolic profiles, or it could indicate insufficient statistical 
power to detect small changes in metabolomic profile. Further investigation is needed to 
determine the cause of these inconsistencies.  
5.2 Study Limitations: 
 While using saliva as a medium for identifying metabolic pathways is both inexpensive 
and non-invasive, there are disadvantages associated with its use in this capacity. Saliva samples 
were collected immediately prior to and following outdoor physical activity. Therefore, any 
metabolic features that take more than a 2-hour window to become established in the body would 
not have shown up in our analysis. Also, this method did not take into account any exposures to 
air pollution or physical activity prior to the allotted sampling time period. Research has shown 
that exposure to air pollutants in the previous 24-48 hours can impact health outcomes more 
significantly than immediate acute exposures (Han & Naeher 2005). Additionally, saliva as a 
medium does not include solely human metabolic processes but also contains byproducts from 
bacterial metabolic processes (Ishikawa et al. 2016).  
 Additionally, our study methods involved measuring multiple factors simultaneously.  
We attempted to control for this in our linear mixed regression models, but because some of the 
factors are inherently correlated, we may not have separated them perfectly. Dose and physical 
activity, for example, posed a significant challenge. These two factors are highly correlated with 
each other (because dose is calculated using minute ventilation data), so disentangling the effects 
caused by each is very important. We attempted to separate these confounding effects by 
comparing regression models that controlled for activity with models that did not. For this 
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portion of the analysis, we focused on BC and PNC because of their high biological relevance. 
The significant metabolites found associated with dose while controlling for activity, dose while 
not controlling for activity, and activity while not controlling for any pollutant metrics did not 
overlap at all. When comparing models with dose as a predictor that did control for activity to 
models that did not control for activity, we can suppress the biochemical effects of changes in 
heart rate caused by activity. Although strongly influenced by physical activity, the cumulative 
dose exposure metric is a function of several additional factors as well. For example, two persons 
with similar activity levels could experience different inhaled doses if one person’s activity 
occurred during time periods when pollutant concentration levels were low while the other 
person’s occurred while concentrations were high. In addition, if the persons had different levels 
of physical fitness with respect to aerobic activity, then the more fit person would experience a 
smaller increase in ventilation rate for the same increase in the accelerometer-derived activity 
parameter. Finally, FVC is an important predictor of dose and is also sensitive to height. 
Therefore, a taller individual would have a higher inhaled dose than a shorter individual all else 
being equal. Modeling dose poses a unique challenge because dose may be a function of body 
and/or lung size in addition to high one-minute ambient concentration levels. We did not 
separate these factors in our models, meaning that our dose measurements could change for 
reasons related and unrelated to activity.  
 Due to the nature of the Mummichog analysis, small changes in an effect size could 
potentially change the distribution of activated pathways. It is possible that this study does not 
have enough statistical power to observe changes at the small levels of variation in pollution 
metrics measured. Part of this problem occurs due to our study design in which participants’ 
exposures are measured over a course of hours rather than for days or weeks at a time.  
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 Although this study did not yield results that display a strong correlation between 
pollution exposure and changes in metabolic profiles, especially across pollutant metrics, we 
have reason to believe this area of study is promising in the early detection of disease. An 
ongoing study in Atlanta using plasma metabolomics data to examine the effects of near-
roadway air pollution exposure on metabolite production did find compelling results. The only 
notable difference between the studies is that the exposure period utilized in their study is one 
week rather than 2 hours. This suggests that acute pollution exposure may take more than 2 
hours to have a measurable effect on the salivary metabolome. (Liang et al. n.d.) 
 It is critical to understand the challenges involved in interpreting untargeted, high-
resolution metabolomics data. We used an online metabolic database to identify statistically 
significant metabolites in our study. Because the database of human metabolites is limited, many 
significant results were left unknown after our final analysis.  
5.3 Conclusions:  
 This study provided insight into the short-term effects of acute air pollution exposure on 
metabolite production. We identified 48 metabolic pathways that showed significant correlation 
with air pollution exposure. Current contributions to the field of untargeted, high-resolution 
metabolomics data will allow future research to better explain the relationship between air 
pollution exposure and metabolite production. Our research suggests that while high-resolution 
metabolomics shows potential for reliably identifying biomarkers of pollutant-related stress, 
there is still much room for further development in this field. As the number of identified 
metabolites in online databases increases, programs such as Mummichog will develop the ability 
to identify a growing number of metabolites and associated pathways.  
 Future challenges include standardizing data collection, analysis, and reporting methods.  
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TABLES AND FIGURES 
 
Table 1. Sample Characteristics 
Characteristics N (%) 
Sex 
     Female 
     Male 
 
18 (31.58) 
39 (68.42) 
Race 
     Black 
     White 
     Asian 
 
11 (19.30) 
41 (71.93) 
5 (8.77) 
*Age (yrs) 26.26 (7.94) 
*Weight (kg) 70.83 (13.77) 
*Height (cm) 172.45 (9.38) 
*BMI  (kg/m2) 23.64 (3.35) 
*Indicates values are Mean (SD) 
 
 
Table 2. Mean Pollutant Metric Values 
Pollutant Metric Mean (SD) 
Particulate Matter (PM2.5) (µg/m3) 
     Concentration 
     Exposure 
     Dose 
     Max 
 
13.23 (4.92) 
1833.41 (649.97) 
80.10 (40.01) 
1.26 (0.51) 
Particle Number Concentration (PNC) (particles/cm3) 
     Concentration 
     Exposure 
     Dose 
     Max 
 
10.95 (3.35) 
1644.69 (1051.28) 
66.06 (32.30) 
1.38 (0.55) 
Black Carbon (BC) (µg/m3) 
     Concentration 
     Exposure 
     Dose 
     Max 
 
0.64 (0.17) 
92.94 (30.23) 
3.93 (1.58) 
0.08 (0.05) 
Ozone (O3) (ppm) 
     Concentration 
     Exposure 
     Dose 
     Max 
 
48.52 (12.53) 
7414.25 (3813.63) 
295.13 (112.85) 
4.21 (1.07) 
Activity 42.24 (12.77) 
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Table 3. Number of Significant Features per Pollutant Metric 
Pollutant Metric C18 HILIC Total 
Black Carbon (BC) 
     Concentration 
     Dose 
     Exposure 
     Max 
 
61 
41 
37 
48 
 
79 
48 
78 
39 
 
140 
89 
115 
87 
Ozone (O3) 
     Concentration 
     Dose 
     Exposure 
     Max 
 
39 
45 
55 
32 
 
53 
47 
80 
65 
 
92 
92 
135 
97 
Particulate Matter (PM2.5) 
     Concentration 
     Dose 
     Exposure 
     Max 
 
41 
28 
50 
29 
 
58 
63 
66 
60 
 
99 
91 
116 
89 
Particle Number Concentration (PNC) 
     Concentration 
     Dose 
     Exposure 
     Max 
 
52 
70 
77 
73 
 
66 
89 
75 
99 
 
118 
159 
152 
172 
Values represent the number of features that show significant associations with changes in each 
pollutant metric after applying the FDR adjustment. 
 
 
Table 4.  Mummichog output: 
a. HILIC Plasma Column 
Pathway	Name	 Overlap	Size	
Pathway	
Size	
P-value	
(Raw)	
P-value1	
	
Metric	
	
Alanine	and	aspartate	metabolism*	 3	 22	 0.08029	 0.00586	 BC	exp;	O3	exp;	PNC	conc,	exp	
Aminosugars	metabolism	 3	 28	 0.03517	 0.00096	 PNC	conc	
Androgen	and	estrogen	biosynthesis	and	
metabolism	 2	 43	 0.41914	 0.03787	 PNC	dose	
Arginine	and	proline	metabolism*	 3	 38	 0.18226	 0.00319	 O3	exp;	PNC	dose,	exp,	max	
Ascorbate	(Vitamin	C)	and	aldarate	
metabolism	 3	 15	 0.02524	 0.00008	 PNC	max	
Aspartate	and	asparagine	metabolism	
3	 67	
	
0.10978	
	
0.00301	
	
O3	conc;	PNC	conc,	
max;	BC	conc;	PM	
exp	
Beta-Alanine	metabolism**	 2	 14	 0.1234	 0.00084	 O3	exp,	max;	PNC	exp,	max;	ACT	
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Biopterin	metabolism	 2	 15	 0.14613	 0.01627	 BC	exp	
Butanoate	metabolism	 2	 22	 0.11251	 0.00473	 PNC	conc,	exp;	ACT	
Carnitine	shuttle	 2	 14	 0.13733	 0.01545	 PNC	exp	
De	novo	fatty	acid	biosynthesis	 2	 19	 0.20215	 0.00189	 PM	max;	PNC	dose,	max;	ACT	
Drug	metabolism	-	other	enzymes	 2	 17	 0.08654	 0.00125	 BC	conc,	exp;	PM	dose;	PNC	exp,	max	
Fatty	Acid	Metabolism	 2	 16	 0.15399	 0.00118	 PNC	max	
Galactose	metabolism	 2	 38	 0.35931	 0.0291	 PNC	dose	
Glutamate	metabolism	 2	 12	 0.03787	 0.00177	 PNC	conc,	exp	
Glutathione	metabolism*	 2	 10	 0.02669	 0.00142	 BC	conc;	PNC	conc,	exp	
Glycerophospholipid	metabolism*	 2	 42	 0.30505	 0.01998	 O3	exp;	PNC	conc,	dose	
Glycine,	serine,	alanine	and	threonine	
metabolism	 2	 47	 0.1991	 0.0165	
BC	conc,	O3	conc,	
PNC	conc	
Glycolysis	and	gluconeogenesis**	 3	 39	 0.19229	 0.00345	 O3	exp,	PNC	conc,	PM	exp	
Glycosphingolipid	metabolism	 2	 25	 0.09688	 0.00603	 O3	max	
Hexose	phosphorylation**	 2	 17	 0.17882	 0.02007	 BC	exp	
Histidine	metabolism	 4	 21	 0.00756	 0.00035	 O3	exp;	PNC	conc,	exp	
Leukotriene	metabolism*	 3	 44	 0.16632	 0.00455	 PM	max;	PNC	conc,	exp,	max;	BC	dose	
Linoleate	metabolism	 3	 19	 0.04746	 0.00012	 PNC	conc,	dose,	max	
Methionine	and	cysteine	metabolism*	 5	 48	 0.00724	 0.00047	
PNC	conc,	exp,	
max;	BC	max,	dose,	
exp;	O3	exp	
Prostaglandin	formation	from	arachidonate	 3	 57	 0.46357	 0.00624	 PNC	max,	PM	max	
Purine	metabolism	 5	
48	 0.06258	 0.00367	
BC	exp,	dose;	PM	
conc;	PNC	conc,	
dose	
Pyrimidine	metabolism	 3	 41	 0.21276	 0.00404	 O3	exp;	PNC	conc,	exp	
Pyruvate	metabolism	 2	 14	 0.05052	 0.00219	 PNC	conc,	exp;	O3	exp	
Saturated	fatty	acids	beta-oxidation	 2	 9	 0.05614	 0.00031	 PNC	max,	exp	
Selenoamino	acid	metabolism	 2	 17	 0.10183	 0.00501	 PM	max,	PNC	exp	
Squalene	and	cholesterol	biosynthesis	 2	 25	 0.18485	 0.03975	 BC	conc,	exp	
TCA	cycle	 3	 15	 0.02753	 0.00336	 BC	exp	
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Tyrosine	metabolism*	 3	 85	 0.3916	 0.01797	 PNC	conc	
Urea	cycle/amino	group	metabolism*	 3	 47	 0.124	 0.00269	
PNC	conc,	dose,	
max;	O3	conc,	
dose;	ACT	
Vitamin	B3	(nicotinate	and	nicotinamide)	
metabolism	 3	 20	 0.06349	 0.00503	
PNC	conc,	exp,	
dose	
Vitamin	B9	(folate)	metabolism	 3	 13	 0.02011	 0.00305	 PNC	conc,	exp;	BC	exp	
Vitamin	E	metabolism*	 2	 23	 0.08384	 0.00511	 O3	max	
Xenobiotics	metabolism*	 2	 54	 0.32002	 0.03786	 O3	max	
1Mummichog-calculated p-value takes into consideration the number of metabolite overlaps on 
given pathway. 
*Pathways found in previous studies to be associated with air pollution exposure. 
**Pathways found in previous studies to be associated with physical activity. 
Values displayed are associated with most significant findings for each pathway. 	
b. C18 Plasma Column 
Pathway	Name	 Overlap	Size	
Pathway	
Size	
P-value	
(Raw)		
P-value1	
	
Metric	
	
Alanine	and	aspartate	metabolism	 2	 20	 0.11455	 0.01363	
PNC	dose	
Androgen	and	estrogen	biosynthesis	and	
metabolism	 2	 55	 0.28777	 0.00167	
PM	conc;	BC	conc,	
dose;	PNC	conc,	
exp	
C21-steroid	hormone	biosynthesis	and	
metabolism	 3	 70	 0.14908	 0.00005	
PM	conc;	O3	exp,	
dose;	BC	conc,	
dose;	PNC	exp;	
ACT	
De	novo	fatty	acid	biosynthesis	 2	 16	 0.03645	 0.00001	 PM	conc	
Drug	metabolism	-	cytochrome	P450*	 2	 32	 0.03351	 0.00001	
O3	dose,	PNC	dose	
Galactose	metabolism	 2	 36	 0.12282	 0.00914	 BC	dose	
Glycerophospholipid	metabolism	 2	 39	 0.19424	 0.00006	
BC	exp,	PNC	exp	
Linoleate	metabolism	 2	 19	 0.05384	 0.00556	 BC	conc	
Lysine	metabolism	 2	 22	 0.22663	 0.03218	 PNC	exp	
N-Glycan	biosynthesis	 2	 14	 0.03047	 0.00412	 BC	conc	
Pentose	and	glucuronate	
interconversions**	 2	 14	 0.0283	 0.00001	 PM	conc	
Porphyrin	metabolism*	 3	 14	 0.00681	 0.00237	 PNC	dose	
Purine	metabolism	 2	 42	 0.05525	 0.00002	 O3	dose	
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Pyrimidine	metabolism	 2	 49	 0.24386	 0.00094	 PM	conc	
Tryptophan	metabolism	 3	 47	 0.30195	 0.02751	 PNC	exp	
Tyrosine	metabolism	 2	 83	 0.08845	 0.00506	 BC	max,	PNC	exp,	O3	exp	
Urea	cycle/amino	group	metabolism	 3	 40	 0.22284	 0.0158	
PNC	exp	
Vitamin	A	(retinol)	metabolism*	 2	 32	 0.12497	 0.00013	 PM	conc,	dose;	PNC	dose	
Xenobiotics	metabolism	 2	 52	 0.26579	 0.00126	 PM	conc	
1Mummichog-calculated p-value takes into consideration the number of metabolite overlaps on 
given pathway. 
*Pathways found in previous studies to be associated with air pollution exposure. 
**Pathways found in previous studies to be associated with physical activity. 
Values displayed are associated with most significant findings for each pathway. 	
 
Figure 1. Manhattan Plots for PNC max with FDR-corrected significance levels 0.05, 0.10, and 
0.20 represented by the red, blue, and black lines, respectively	a.	
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	b.
	
Figure 1a. and 1b. represent the Manhattan plots for PNC max associations from the C18 and 
HILIC datasets, respectively.  			 	
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Figure 2. Manhattan Plots for BC dose with FDR-corrected significance levels 0.05, 0.10, and 
0.20 represented by the red, blue, and black lines, respectively  a.	
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b.
	
Figure 2a. and 2b. represent the Manhattan plots for BC dose associations from the C18 and 
HILIC datasets, respectively.  	 	
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